July 6, 2020 | COVID-19 Briefings

COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration

Free COVID-19 STAT Intelligence Briefings Email Digest

Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.

Specific COVID-19 Preanalytical Issues Clinical Laboratories Should Consider

Several points of the preanalytical clinical laboratory testing process affect quality of results

Explanation of preanalytical issues with SARS-CoV-2 (COVID-19) testing in clinical laboratories and what to expect in the event of a second wave of infections in the fall.

FDA Issues Warning Letter to KBMO Diagnostics for Advertising Unauthorized At-Home SARS-CoV-2 Testing

Explanation of warnings issued to KBMO Diagnostics related to at-home COVID-19 testing.